Coronavirus - COVID 19 HAS veille

View Page

Bonjour 30/03/2020. C’est la première annonce massue du genre https://www.jnj.com/coronavirus. Est-ce la dernière ? La multinationale américaine Johnson & Johnson (J&J) annonce un « candidat vaccin » contre le COVID-19 et ce grâce à un partenariat historique avec le Ministère de la santé américain. Elle s’engage aussi à fournir  milliard de doses de vaccins dans le monde pour…

This guidance has been prepared to provide members / health professionals working in paediatrics and child health with advice around the ongoing outbreak of COVID-19. It also provides signposts and links to further information developed by national bodies.

We will update this guidance on a regular basis as new data becomes available. We'll work with others to bring together the best available information. Advice and guidance should be used alongside local operational policies developed by your organisation.

AbstractBackground. The novel coronavirus SARS-CoV-2 is a newly emerging virus. The antibody response in infected patient remains largely unknown, and the clin

We illustrated three different clinical and biological types of evolution in five
patients infected with SARS-CoV-2 with detailed and comprehensive viral sampling strategy.
We believe that these findings will contribute to a better understanding of the natural
history of the disease and will contribute to advances in the implementation of more
efficient infection control strategies.

Abstract Background At present, the severity of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been a focal point. Methods To assess the factors associate

Covid-19 et hydroxychloroquine : prudence

Updates on the respiratory illness that has infected hundreds of thousands of people and killed several thousand.

With rates of hospitalisation and mortality from novel coronavirus disease 2019 (COVID-19)
increasing, there is understandable concern across the UK for medical professionals
and the general public. We hope to highlight the challenges faced by children and
health-care professionals involved in their care, and propose key strategies to address
these challenges.

Open access platform which gathers all available information regarding global clinical trials for COVID-19